Work

Exploratory analysis of the visceral disease (VD) patient subset in COU-AA-301, a phase III study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.14

Authors: Oscar B. Goodman, Thomas W. Flaig, Arturo Molina, Peter Mulders, Henrik Suttmann, Jinhui Li, Thian San Kheoh, Johann Sebastian De Bono, Howard I. Scher

Institutions: Comprehensive Cancer Centers of Nevada, University of Colorado Cancer Center, Radboud University Medical Center, Janssen Research & Development (United States), Royal Marsden NHS Foundation Trust, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589962806

Cites:

Cited by: 6

Related to: 10